Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Aratana Therapeutics Inc    PETX

ARATANA THERAPEUTICS INC (PETX)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/18 04:00:00 pm
4.42 USD   +6.76%
2018ARATANA THERAPEUTICS INC : quaterly earnings release
2017ARATANA THERAPEUTICS INC : quaterly earnings release
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/14/2019 01/15/2019 01/16/2019 01/17/2019 01/18/2019 Date
4.02(c) 4.21(c) 4.1(c) 4.14(c) 4.42(c) Last
1 543 834 1 802 715 1 242 879 577 914 4 915 704 Volume
-8.01% +4.73% -2.61% +0.98% +6.76% Change
More quotes
Financials (USD)
Sales 2018 36,8 M
EBIT 2018 -10,2 M
Net income 2018 -16,1 M
Finance 2018 36,6 M
Yield 2018 -
Sales 2019 43,7 M
EBIT 2019 -8,10 M
Net income 2019 -11,4 M
Finance 2019 42,6 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 4,84x
EV / Sales2019 3,95x
Capitalization 215 M
More Financials
Company
Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule... 
Sector
Pharmaceuticals
Calendar
03/14Earnings Release
More about the company
Surperformance© ratings of Aratana Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ARATANA THERAPEUTICS INC
01/17ARATANA THERAPEUTICS : ' Board of Directors Appoints Craig Tooman Chief Executiv..
PR
01/04ARATANA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K..
AQ
2018ARATANA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
2018ARATANA : 3Q Earnings Snapshot
AQ
2018ARATANA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Fina..
AQ
2018ARATANA THERAPEUTICS : Reports Third Quarter 2018 Financial Results
PR
2018ARATANA THERAPEUTICS : to Report Third Quarter 2018 Financial Results
PR
2018ARATANA THERAPEUTICS : to Present at CL King and Associates Best Ideas Conferenc..
PR
2018ARATANA THERAPEUTICS : Management's Discussion and Analysis of Financial Conditi..
AQ
2018ARATANA : 2Q Earnings Snapshot
AQ
More news
Analyst Recommendations on ARATANA THERAPEUTICS INC
More recommendations
Sector news : Veterinary Drugs
01/18ELI LILLY AND : Lilly Reports Favorable Cyramza Results in Phase 3 Liver Cancer ..
DJ
01/18ABBVIE : Says Imbruvica Didn't Meet Endpoints in Pancreatic Cancer Study
DJ
01/18Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
RE
01/18FDA Approves Herceptin Biosimilar Ontruzant Breast Cancer Drug
DJ
01/18ELI LILLY AND : Sarcoma Drug Combo Proves Ineffective in Trials--Update
DJ
More sector news : Veterinary Drugs
Chart ARATANA THERAPEUTICS INC
Duration : Period :
Aratana Therapeutics Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ARATANA THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 6,90 $
Spread / Average Target 56%
EPS Revisions
Managers
NameTitle
Steven St. Peter President, Chief Executive Officer & Director
Wendy L. Yarno Non-Executive Chairman
Craig A. Tooman Chief Financial Officer & Treasurer
John W. Vander Vort Independent Director
Laura A. Brege Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ARATANA THERAPEUTICS INC-27.90%215
ZOETIS-1.11%40 641
DECHRA PHARMACEUTICALS16.72%3 189
JINYU BIO-TECHNOLOGY CO LTD49.34%2 631
PHIBRO ANIMAL HEALTH CORP-0.31%1 294
VIRBAC2.99%1 126